Impact of obesity and smoking on psoriasis presentation and management

Archives of Dermatology

Volumn 141, Issue 12, 2005, Pages 1527-1534

  Herron, Mark D ^d   Hinckley, Michael ^a   Hoffman, Matthew S ^a   Papenfuss, Jason ^b   Hansen, Christopher B ^c   Callis, Kristina P ^a   Krueger, Gerald G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d Health Sciences Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHOTREXATE; PSORALEN;

ADULT; ARTICLE; BODY IMAGE; CIGARETTE SMOKING; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OBESITY; ONSET AGE; PERCEPTION; PHENOTYPE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUBLIC HEALTH; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ADRENAL CORTEX HORMONES; ADULT; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PSORIASIS; RISK FACTORS; SMOKING; UTAH;

EID: 29144457541     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.141.12.1527     Document Type: Article

References (53)

1. Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Online Prevalence Data, 1995-2002. Available at: http://apps.nccd.cdc.gov/brfss/. Accessed January 2004.
2. Ahluwalia IB, Mack KA, Murphy W, Mokdad AH, Bales VS: Division of Adult and Community Health; National Center for Chronic Disease Prevention and Health Promotion. State-specific prevalence of selected chronic disease-related characteristics: behavioral risk factor surveillance system. 2001. MMWR Surveill Summ. 2003;52:1-80.
3. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79.
4. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
5. Ford ES, Moriarty DG, Zack MM, Mokdad AH, Chapman DP. Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System. Obes Res. 2001;9:21-31.
6. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The continuing epidemic of obesity in the United States. JAMA. 2000;284:1650-1651.
7. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA. 1999;282:1519-1522.
8. Vogele C, Florin I. Psychophysiological responses to food exposure: an experimental study in binge eaters. Int J Eat Disord. 1997;21:147-157.
9. Yanovski SZ. Binge eating disorder and obesity in 2003: could treating an eating disorder have a positive effect on the obesity epidemic? Int J Eat Disord. 2003;34(suppl):S117-S120.
10. Bulik CM, Reichborn-Kjennerud T. Medical morbidity in binge eating disorder. Int J Eat Disord. 2003;34(suppl):S39-S46.
11. Kriska AM, Saremi A, Hanson RL, et al. Physical activity, obesity, and the incidence of type 2 diabetes in a high-risk population. Am J Epidemiol. 2003;158:669-675.
12. Elley CR, Kerse NM, Arroll B. Why target sedentary adults in primary health care? baseline results from the Waikato Heart, Health, and Activity Study. Prev Med. 2003;37:342-348.
13. Wilbur J, Chandler PJ, Dancy B, Lee H. Correlates of physical activity in urban Midwestern Latinas. Am J Prev Med. 2003;25(suppl 1):69-76.
14. Giammattei J, Blix G, Marshak HH, Wollitzer AO, Pettitt DJ. Television watching and soft drink consumption: associations with obesity in 11- to 13-year-old schoolchildren. Arch Pediatr Adolesc Med. 2003;157:882-886.
15. Bobak M, Skodova Z, Marmot M. Beer and obesity: a cross-sectional study. Eur J Clin Nutr. 2003;57:1250-1253.
16. Grunbaum JA, Kann L, Kinchen SA, et al. Youth risk behavior surveillance: United States, 2001. MMWR Surveill Summ. 2002;51(SS-4):1-62.
17. Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2002;47:821-833.
18. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000;356:385-390.
19. Shupack J, Abel E, Bauer E, et al. Cyclosporine as maintenance therapy in patients with severe psoriasis. J Am Acad Dermatol. 1997;36:423-432.
20. Stiller MJ, Pak GH, Kenny C, et al. Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis: an assessment of clinical significance when viewed as a risk factor for cardiovascular disease. J Am Acad Dermatol. 1992;27:434-438.
21. Shibata N, Hayakawa T, Hoshino N, Minouchi T, Yamaji A, Uehara M. Effect of obesity on cyclosporine trough concentrations in psoriasis patients. Am J Health Syst Pharm. 1998;55:1598-1602.
22. Brick JE, Moreland LW, Al-Kawas F, Chang WW, Layne RD, DiBartolomeo AG. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients. Semin Arthritis Rheum. 1989;19:31-44.
23. Willkens RF. Short term efficacy of methotrexate in the treatment of rheumatoid arthritis. J Rheumatol Suppl. 1985;12:21-24.
24. Roenigk HH Jr, Bergfeld WF, St Jacques R, Owens FJ, Hawk WA. Hepatotoxicity of methotrexate in the treatment of psoriasis. Arch Dermatol. 1971;103:250-261.
25. Nyfors A, Poulsen H. Liver biopsies from psoriatics related to methotrexate therapy: findings in 123 consecutive non-methotrexate treated patients. Acta Pathol Microbiol Scand A. 1976;84:253-261.
26. O'Connor GT, Olmstead EM, Zug K, et al. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis. Arch Dermatol. 1989;125:1209-1217.
27. Naldi L, Parazzini F, Brevi A. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol. 1992;127:212-217.
28. Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol. 1999;135:1479-1484.
29. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol. 1999;135:1490-1493.
30. Lacy CF, Armstrong LL, Goldman MP, et al. Drug Information Handbook 2002-2003. 10th anniversary ed. Hudson, Ohio: Lexi-Comp; 2002:1457.
31. Hebel SK, ed. Drug Facts and Comparisons. St Louis, Mo: Facts & Comparisons; 2003:A-19.
32. Mosteller RD. Simplified calculation of body surface area. N Engl J Med. 1987;317: 1098.
33. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, Md: National Heart, Lung, and Blood Institute; June 17, 1998.
34. Stunkard AJ, Sorensen T, Schulsinger F. Use of the Danish Adoption Register for the study of obesity and thinness. Res Publ Assoc Res Nerv Ment Dis. 1983;60:115-120.
35. Bhuiyan AR, Gustat J, Srinivasan SR, Berenson GS. Differences in body shape representations among young adults from a biracial (black-white), semirural community. Am J Epidemiol. 2003;158:792-797.
36. Finner H. On a monotonicity problem in step-down multiple test procedures. J Am Stat Assoc. 1993;88:920-923.
37. Krueger GG, Duvic M. Epidemiology of psoriasis: clinical issues. J Invest Dermatol. 1994;102:14S-18S.
38. Fratino P, Bellomo G, Pelfini C, Bellazzi R, Jucci A, Rabbiosi G. Insulin receptors in psoriasis. Acta Derm Venereol Suppl (Stockh). 1979;87:38-40.
39. Nowlin N, Solomon H. Weight loss and psoriasis [letter]. Arch Dermatol. 1976;112:1465.
40. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32:982-986.
41. Binazzi M, Calandra P, Lisi P. Statistical association between psoriasis and diabetes: further results. Arch Dermatol Res. 1975;254:43-48.
42. Lindegard B. Diseases associated with psoriasis in a general population of 159 200 middle-aged, urban, native Swedes. Dermatologica. 1986;172:298-304.
43. Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314-320.
44. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient member survey. Arch Dermatol. 2001;137:280-284.
45. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401-407.
46. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002;47:512-518.
47. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1380 patients. J Invest Dermatol. 1988;91:197-201.
48. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol. 1978;99:469-475.
49. Nieto-Garcia FJ, Bush TL, Keyl PM. Body mass definitions of obesity: sensitivity and specificity using self-reported weight and height. Epidemiology. 1990;1:146-152.
50. Palta M, Prineas RJ, Berman R, Hannan P. Comparison of self-reported and measured height and weight. Am J Epidemiol. 1982;115:223-230.
51. Gunnell D, Berney L, Holland P, et al. How accurately are height, weight and leg length reported by the elderly, and how closely are they related to measurements recorded in childhood? Int J Epidemiol. 2000;29:456-464.
52. Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soz Praventivmed. 2001;46:S3-42.
53. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238-1245.